ENZB insider buying & filings

ENZBENZO BIOCHEM INC

—

11 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Aug 20 · scanned 5m ago

No price data yet — the yfinance scanner hasn't produced bars for ENZB.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Aug 20RETURNRadoff Bradley LouisDirectorindirect430,000 sh—

Aug 20RETURNRadoff Bradley LouisDirectordirect4,533,779 sh—

Aug 20RETURNPully Steven JDirectordirect239,992 sh—

Aug 20RETURNEckert PatriciaChief Financial Officerindirect28,328 sh—

Aug 20RETURNCannon KaraChief Executive Officerindirect45,065 sh—

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice